Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03255291 · ClinicalTrials.gov registry record · NA

Communicating Multiple Disease Risks: A Translation of Risk Prediction Science

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
554
Enrollment target

NCT03255291 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 554 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03255291, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
554 participants
Enrollment target

Study Summary

Epidemiology seeks to improve public health by identifying risk factors for cancer and other diseases and conveying that information to relevant audiences (e.g., physicians, the public). The audience is presumed to understand and use that information to make appropriate decisions about lifestyle behaviors and medical treatments. Yet, even though a single risk factor can affect the risk of multiple health outcomes, this information is seldom communicated to people in a way that optimizes their understanding of the importance of engaging in a single healthy behavior. Providing individuals with the ability to understand how a single behavior (obtaining sufficient physical activity) could affect their risk of developing multiple diseases could foster a more coherent and meaningful picture of the behavior's importance in reducing health risks, increase motivation and intentions to engage in the behavior, and over time improve public health. The proposed study translates epidemiological data about five diseases that cause significant morbidity and mortality (i.e., colon cancer, breast cancer (women), heart disease, diabetes, and stroke) into a visual display that conveys individualized risk estimates in a comprehensible, meaningful, and useful way to diverse lay audiences.

Interventions

  • OTHER Surveys
  • OTHER Text message reminders
  • BEHAVIORAL Risk Assessment App
  • BEHAVIORAL Audio Recording - Sleep
  • BEHAVIORAL Audio Recording - Exercise

Trial Details

FieldValue
Enrollment Target 554 participants
Start Date 2017-06-27
Est. Completion 2019-01-03
Phase NA

What the Registry Record Tells You About NCT03255291

The ClinicalTrials.gov registry entry for NCT03255291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 554 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Surveys is the first listed.

NCT03255291 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03255291 about?

NCT03255291 is a clinical study titled "Communicating Multiple Disease Risks: A Translation of Risk Prediction Science". Epidemiology seeks to improve public health by identifying risk factors for cancer and other diseases and conveying that information to relevant audiences (e.g., physicians, the public). The audience is presumed to understand and use that information to make appropriate decisions about lifestyle beh...

What is the current status of trial NCT03255291?

This trial is currently completed. It is a NA study. The enrollment target is 554 participants. The study started on 2017-06-27. Estimated completion is 2019-01-03.

What interventions are being tested in trial NCT03255291?

The interventions under investigation include: Surveys (OTHER), Text message reminders (OTHER), Risk Assessment App (BEHAVIORAL), Audio Recording - Sleep (BEHAVIORAL), Audio Recording - Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03255291?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.